Literature DB >> 21505968

[Health economical aspects of telemedical glaucoma monitoring].

T Swierk1, C Jürgens, R Grossjohann, S Flessa, F Tost.   

Abstract

BACKGROUND: Telemedical home monitoring of glaucoma patients is not covered by health insurance in Germany. Various clinical studies have indicated that 24 h monitoring of intraocular and blood pressure of glaucoma patients allows a better evaluation of the individual disease condition. If the necessary parameters can be collected with telemedical home monitoring it will be possible to reduce the number of 24 h intraocular pressure profiles which necessitate hospital admission. Therefore inpatient 24 h profiles have been chosen as a health economical allocation base with a presentable economical value for the comparative examination. Assuming an at least identical or even higher clinical outcome of the telemedical glaucoma home monitoring inpatient 24 h profiles were chosen as a health economical allocation base to compare and contrast these methods.
METHODS: All procedures of the inpatient 24 h profiles at the ophthalmic clinic of Greifswald were measured using the stopwatch method. In a 1 day test run all activities of the medical staff were identified and documented in a list and afterwards measurements were carried out over 7 days with several stopwatches to allow the documentation of parallel activities. To determine the consumption of resources in telemedical home monitoring the self-documentation of all employees involved in the research project TT-MV were evaluated. Expert interviews helped to determine the economically relevant data about the applied medical technology, e.g. measuring devices, server and electronic health records.
RESULTS: The number and complexity of the subprocesses of the inpatient 24 h intraocular pressure profiles were significantly higher compared to telemedical home monitoring. The total costs of the inpatient 24 h profiles were 571.21 € per patient including 291.21 € for medical care and 280 € for accommodation. In contrast the total costs of telemedical home monitoring were 288.72 € per patient. A direct cost comparison shows that telemedical home monitoring resulted in lower costs compared to hospital admission of glaucoma patients.
CONCLUSION: Telemedical home monitoring of glaucoma patients is not only effective but also cost-efficient. As modern health care systems have to consider cost efficiency, a randomized, controlled longitudinal clinical study of both methods would be required.

Entities:  

Mesh:

Year:  2011        PMID: 21505968     DOI: 10.1007/s00347-010-2253-1

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  16 in total

Review 1.  The 15D instrument of health-related quality of life: properties and applications.

Authors:  H Sintonen
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

2.  A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments.

Authors:  G Hawthorne; J Richardson; N A Day
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

Review 3.  [Technical options and prospects for telemedical devices in ophthalmology].

Authors:  R Grossjohann; C Jürgens; F Tost
Journal:  Ophthalmologe       Date:  2009-09       Impact factor: 1.059

4.  Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma.

Authors:  Yaniv Barkana; Sarah Anis; Jeffrey Liebmann; Celso Tello; Robert Ritch
Journal:  Arch Ophthalmol       Date:  2006-06

5.  [Fluctuation of intraocular pressure in 24-hour telemonitoring compared to tonometry during normal office hours].

Authors:  C Jürgens; S Antal; K Henrici; R Grossjohann; F H Tost
Journal:  Klin Monbl Augenheilkd       Date:  2009-01-27       Impact factor: 0.700

6.  Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops.

Authors:  Shunsuke Nakakura; Yuya Nomura; Shinsuke Ataka; Kunihiko Shiraki
Journal:  J Glaucoma       Date:  2007-03       Impact factor: 2.503

7.  [Diurnal variation of ocular pressure in open-angle glaucoma with telemonitoring].

Authors:  S Antal; C Jürgens; R Grossjohann; F H Tost
Journal:  Klin Monbl Augenheilkd       Date:  2009-03-17       Impact factor: 0.700

Review 8.  [Possibilities and limitations of telemedical home monitoring in ophthalmology].

Authors:  C Jürgens; R Grossjohann; F Tost
Journal:  Ophthalmologe       Date:  2009-09       Impact factor: 1.059

9.  Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma.

Authors:  Ciro Costagliola; Francesco Parmeggiani; Gianni Virgili; Giuseppe Lamberti; Carlo Incorvaia; Paolo Perri; Claudio Campa; Adolfo Sebastiani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-11-15       Impact factor: 3.117

10.  Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.

Authors:  Joseph Caprioli; Anne L Coleman
Journal:  Ophthalmology       Date:  2008-02-20       Impact factor: 12.079

View more
  3 in total

1.  Teleradiology from the provider's perspective-cost analysis for a mid-size university hospital.

Authors:  Christian Rosenberg; Kristin Kroos; Britta Rosenberg; Norbert Hosten; Steffen Flessa
Journal:  Eur Radiol       Date:  2013-04-19       Impact factor: 5.315

2.  The effectiveness of teleglaucoma versus in-patient examination for glaucoma screening: a systematic review and meta-analysis.

Authors:  Sera-Melisa Thomas; Maya M Jeyaraman; Maya Jeyaraman; William G Hodge; Cindy Hutnik; John Costella; Monali S Malvankar-Mehta
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

3.  Relationship of systemic blood pressure with ocular perfusion pressure and intraocular pressure of glaucoma patients in telemedical home monitoring.

Authors:  Clemens Jürgens; Rico Grossjohann; Frank H W Tost
Journal:  Med Sci Monit       Date:  2012-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.